Columbus A/S
2.2.2026 09:22:48 CET | Globenewswire | Press release
Columbus – Weekly report on share buyback
Columbus – Weekly report on share buyback
Company announcement no. 6/2026
Transactions in the period 26 January 2026 to 30 January 2026
On 30 June 2025, Columbus A/S announced a share buyback programme under which the company will repurchase shares for up to DKK 16m during the period from 30 June 2025 to 11 March 2026, both dates included, as outlined in company announcement no. 8/2025.
The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.
The following transactions were made under the share buyback programme in the period 26 January 2026 to 30 January 2026:
| Number of shares bought | Average purchase price (DKK) | Transaction value (DKK) | |
| Accumulated, last announcement | 1,313,950 | 10.00 | 13,142,781.51 |
| 26 January 2026 | 8,500 | 10.30 | 87,550.00 |
| 27 January 2026 | 10,000 | 10.20 | 102,000.00 |
| 28 January 2026 | 8,500 | 9.97 | 84.727.15 |
| 29 January 2026 | 8,500 | 10.00 | 85,000.00 |
| 30 January 2026 | 8,500 | 9.96 | 84,660.00 |
| Total, 26 January 2026 to 30 January 2026 | 44,000 | 10.09 | 443,937.15 |
| Total accumulated under the programme | 1,357,950 | 10.01 | 13,586,718.66 |
With the transactions stated above, Columbus A/S holds a total of 1,357,950 own shares, corresponding to 1.05% of the Company’s share capital.
For further information, please contact: CFO, Brian Iversen, +45 70 20 50 00 |
Attachments
- SE_06_2026_Weekly_report_on_share_buyback
- Columbus - Share buyback transactions 26 January 2026 to 30 January 2026
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Royal Philips24.8.2026 23:04:56 CEST | Press release
Philips prices EU green bond for EUR 650M
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
Lakefront Receives Transparency Notification from Bank of America
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
Cosmos Health Inc.24.8.2026 21:40:00 CEST | Press release
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
Kitron ASA24.8.2026 17:07:52 CEST | Press release
Kitron revises full-year 2026 outlook upwards
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom